The genomics market is expected to grow at a CAGR of 15% during the forecast period. Rising investments in genomic research and development, Reduction in cost of genetic sequencing, and Increasing demand for creating and upgrading genome databases are some of the significant factors fueling genomics market growth.
Rising investments in genomic research and development
Danaher Corp. - Key news
News type Description
M&A, divestitures, JVs, and partnerships In October 2019, the company announced that it signed an agreement to sell its label-free biomolecular characterization, chromatography hardware and resins, and microcarriers and particle validation standards businesses to Sartorius for approximately $750 million.
In February 2019, the company entered into a definitive agreement with General Electric to acquire the Biopharma business of GE Life Sciences for approximately $21.4 billion.
Organizational restructuring In September 2019, Envista Holdings Corp. (Envista Holdings), a subsidiary of Danaher, announced the closing of its IPO of 26,768,000 shares of its common stock at a price to the public of $22.00 per share.
In June 2019, the company announced that its new dental company would be named Envista Holdings Corp.
Key hiring, CEO, and BU heads In November 2019, the company announced the appointment of Jessica L. Mega and Pardis C. Sabeti to its board of directors.
